论文部分内容阅读
近年来,人们认识到门脉高压性胃病(PHG)是肝硬化患者胃肠道出血的潜在病因之一,但其临床意义尚不确定,各地的研究结果相差悬殊,PHG的发生率从7％-98%不等,PHG引起消化道出血的发生率从4％～40％。本研究旨在评价PHG与肝硬化及门脉高压的临床相关性,着重说明PHG与其它内镜检查及临床表现的一致性,以及PHG发展到消化道出血或死亡的自然史。
In recent years, it is recognized that portal hypertensive gastropathy (PHG) is one of the potential causes of gastrointestinal bleeding in patients with cirrhosis, but its clinical significance is uncertain. The results of studies all over the world vary greatly. The incidence of PHG is from 7% -98%, PHG caused the incidence of gastrointestinal bleeding from 4% to 40%. This study was designed to evaluate the clinical relevance of PHG to cirrhosis and portal hypertension, highlighting the consistency of PHG with other endoscopy and clinical manifestations, and the natural history of PHG development to gastrointestinal bleeding or death.